Change in Pulmonary Function after Incentive Spirometer Exercise in Children with Spastic Cerebral Palsy: A Randomized Controlled Study

Ja Young Choi; Dong-wook Rha; Eun Sook Park

doi:10.3349/ymj.2016.57.3.769

Journal List > Yonsei Med J > v.57(3) > 1032003

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Choi, Rha, and Park: Change in Pulmonary Function after Incentive Spirometer Exercise in Children with Spastic Cerebral Palsy: A Randomized Controlled Study

Original Article

Rehabilitation

Yonsei Medical Journal 2016; 57(3): 769-775.

Published online: 15 March 2016

DOI: https://doi.org/10.3349/ymj.2016.57.3.769

Change in Pulmonary Function after Incentive Spirometer Exercise in Children with Spastic Cerebral Palsy: A Randomized Controlled Study

Ja Young Choi, Dong-wook Rha, Eun Sook Park

Department of Rehabilitation Medicine, Severance Hospital, Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Korea.

Corresponding author: Dr. Eun Sook Park. Department of Rehabilitation Medicine, Severance Hospital, Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. Tel: 82-2-2228-3712, Fax: 82-2-363-2795, pes1234@yuhs.ac

Received 26 May 2015 Revised 23 July 2015 Accepted 3 September 2015

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose

The aim of this study was to investigate the effect of incentive spirometer exercise (ISE) on pulmonary function and maximal phonation time (MPT) in children with spastic cerebral palsy (CP).

Materials and Methods

Fifty children with CP were randomly assigned to two groups: the experimental group and the control group. Both groups underwent comprehensive rehabilitation therapy. The experimental group underwent additional ISE. The forced vital capacity (FVC), forced expiratory volume at one second (FEV₁), FEV₁/FVC ratio, peak expiratory flow (PEF), and MPT were assessed as outcome measures before and after 4 weeks of training.

Results

There were significant improvements in FVC, FEV₁, PEF, and MPT in the experimental group, but not in the control group. In addition, the improvements in FVC, FEV₁, and MPT were significantly greater in the experimental group than in the control group.

Conclusion

The results of this randomized controlled study support the use of ISE for enhancing pulmonary function and breath control for speech production in children with CP.

Keywords: Pulmonary function, incentive spirometer, cerebral palsy

INTRODUCTION

Children with cerebral palsy (CP) are at risk for respiratory dysfunction due to various causes, such as pneumonia, atelectasis, bronchiectasis, sleep apnea, and chronic obstructive lung disease. Restrictive lung disease is also common in patients with CP.1 2 In addition, poor nutritional status, drooling, aspiration, gastroesophageal reflux, impairment of airway clearance due to muscular weakness or incoordination, and poor pulmonary reserve increase the risk of morbidity and mortality as a result of respiratory infection.3 4 5 6 7 8 According to a recently reported study, children with spastic CP have lower pulmonary function than normal, healthy children.9 Poor chest mobility, trunk extensibility, and weak respiratory muscle strength are related to poor respiratory function in children with CP.3 10 11

Incentive spirometer exercise (ISE) is widely used in chest physiotherapy, and it encourages the patient to perform slow and deep inspiration through visual feedback, allowing for the stretching and opening of collapsed airways. ISE is useful as it is inexpensive and simple to use with no known side effects, and also it does not require supervision once the child is trained in its use. Furthermore, achievement of the visual target encourages the children to try their best and thus promotes patient compliance.12 Previous reports demonstrated some beneficial effects of ISE on pulmonary function and arterial blood gases in patients with chronic obstructive pulmonary disease,13 14 15 as well as in patients with ankylosing spondylitis.12

According to a recently published study, feedback respiratory training (FRT) in children with CP leads to improvement in pulmonary function.16 However, there is still a paucity of data regarding the effectiveness of respiratory training on pulmonary function in children with CP.

Maximum phonation time (MPT) represents the ability to maximally sustain a vowel sound after having taken a maximal inspiration. It is widely used to evaluate the efficiency of respiratory mechanisms during phonation, because it is a quick, non-invasive, and inexpensive method. According to a previous report, MPT has been used to objectively assess the degree of severity of dysphonia and to determine the effects of voice therapy. 17 Additionally, it has proven to be a highly reliable measure in voice assessment.18 To the best of our knowledge, the effects of respiratory training on MPT have not yet been investigated in children with CP.

Therefore, the aims of this study were to evaluate the effect of ISE on pulmonary function tests (PFT) and MPT in children with spastic CP.

MATERIALS AND METHODS

This was a prospective, randomized, case-control study (registration number NCT02406404). Ethical approval was granted by the Institutional Review Board and ethics committee of Severance Hospital. Since all of the children in this study were younger than 18 years, informed consent was obtained from the parents of the children who agreed to participate in this study.

Participants

This study was conducted in a rehabilitation hospital affiliated with a university between May 2013 and April 2015. Among the children who were admitted to our hospital for intensive therapy, those who met the following inclusion and exclusion criteria were selected for this study: the inclusion criteria included 1) children with spastic CP between the ages of 8 and 15 years, 2) level I to IV on the Gross Motor Function Classification System (GMFCS), who have the ability to maintain antigravity head and trunk postures, 3) cognitive and cooperative function allowing for pulmonary function measurements, and 4) no history of psychiatric or neurological disorders other than CP. The exclusion criteria included 1) any uncontrolled, clinically significant medical condition, such as coexistent cardiac disease or respiratory disease, 2) children with cognitive impairment who are unable to comply with the protocol-required procedure, 3) children with the presence or history of tracheostomy, 4) children who are taking medications that can affect respiratory function, and 5) children with bone deformities of the spine, such as kyphosis or scoliosis. As a result, 60 children met the criteria, and 10 eligible participants declined to participate in the study. Thus, 50 children participated in this study. A computerized random generator was used to assign each participant to the experimental group (n=25) or the control group (n=25) (Fig. 1).

Study design

Participants in the experimental group were treated using a flow-oriented incentive spirometer (DHD CliniFLO®, Smiths medical ASD, Inc., Rockland, MA, USA) (Fig. 2), which has a chamber-containing ball. The ball is raised in its chamber upon generation of different inspiratory flow rates (six flow settings from 100 mL/sec to 600 mL/sec) by participants breathing through a mouthpiece. The children in the ISE group were instructed on how to use the incentive spirometer. After a quiet expiration, they were encouraged to close their lips tightly around the mouthpiece and then inhale slowly and deeply until the ball in the spirometer lifted. They were then instructed to hold their breath for as long as possible, or for at least 5 seconds, and then to breathe out slowly. Corresponding to the inspiratory flow, the balls lifted and remained suspended by the sustained inspiratory flow, which served as visible feedback. The flow rate progressively increased at 100 mL/sec intervals from 100 mL/sec to 600 mL/sec, if the participants could maintain the balls lifted at least 5 seconds.

The participants were encouraged to use the device for 10–15 breaths per session. Ten training sessions were performed daily for 4 weeks. They trained themselves with checklist in a hospital room with regular supervision twice a week. Children in both groups received conventional physical therapy and occupational therapy that focused on gross and fine motor tasks five times per week for a period of four weeks.

Outcome measures

The Gross Motor Function Measure (GMFM)-66 was used to assess improvement in gross motor function. GMFM-66 has been shown to be a reliable and valid measure of gross motor function and useful for measuring the effect of intervention programs.19

The PFT was done in the resting period at least 1 hour after physical and occupational therapy and ISE. The PFT was performed before training and at the end of the 4-week training period by the same investigator. PFT was performed using a portable spirometer (Micro Spirometer MS01; Micro Medical Ltd., Kent, UK) assessing forced expiratory volume at one second (FEV₁) and forced vital capacity (FVC). A peak flow meter (ASSESS® Respironics International Inc., Murrysville, PA, USA) was also used to measure peak expiratory flow (PEF). The children were seated on a chair with the head and trunk straight and the hip and knee joints flexed to 90° with use of external supporting pad. For the children at GMFCS level IV, the test was performed in a chair sitting with external supporting pad and also the shoulder supported by their parent's hands. We used various chairs in consideration of each child's size. The children were told to inhale as deeply as possible and to blow their entire lung volume through the spirometer. This process was repeated at least three times, and the highest value was selected. PFT data were normalized for age, gender, and height, and the predicted FEV₁ and FVC values (%) were calculated using the equations provided by Yoon, et al.20 based on values acquired from healthy Korean children. These calculations were used to obtain percent predicted values for FVC (FVC, %) and FEV₁ (FEV₁, %).

Maximal phonation time (MPT) testing was conducted in a quiet room with children seated on a chair in the same body position with measurement of PFT. The children were asked to inhale deeply and then produce a sustained phonation of the vowel /a:/ at a comfortable pitch and loudness in the seated position for as long as possible. The children were allowed three trials in a row with a 30-second break in between. Each phonation was video recorded (Handycam DCR-SR67; Sony Co., Tokyo, Japan), and the longest value was used for analysis.

Statistical analysis

The baseline characteristics of the two groups were compared using the Student's t-test or Mann-Whitney test for continuous variables and the chi-square test for categorical variables. Comparisons of pulmonary function before and after training within each group were made using the paired samples t-test or Wilcoxon signed rank test. Differences between the experimental group and the control group were assessed using an independent samples t test or Mann-Whitney test. Statistical software SPSS 20.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. The level of significance was chosen to be 0.05.

RESULTS

Although 50 children with CP were recruited for the study, two children in the control group did not complete the study protocol due to early discharge. As a result, 25 children in experimental group and 23 children in control group were included in this study. Their mean age was 11.6 years old (±2.3 years). The demographic and baseline characteristics of the study population are shown in Table 1. The two groups were not significantly different in gestational age, birth weight, height, or body weight. The PFT parameters and GMFM scores at baseline were not significantly different between the two groups.

FEV₁, FVC, PEF, and MPT increased significantly after ISE in the experimental group, compared with baseline data. The improvements in FEV₁, FVC, and MPT were significantly higher in the experimental group than in the control group (Table 2).

Compared to baseline GMFM-66 scores, GMFM scores significantly increased after 4 weeks of training in both groups, although improvements in the GMFM scores were not significantly different between the two groups.

There were no significant relationships between GMFM-66 scores and PFT parameters, such as FEV₁, FVC and PEF, but significant correlation with MPT (Table 3); and also the improvements in GMFM-66 scores did not significantly relate to changes in pulmonary function or MPT.

DISCUSSION

The FEV₁, FVC, and FEV₁/FVC ratio are useful parameters for assessing restrictive lung disease. On the other hand, PEF is a measure of the maximal or peak flow produced during exhalation with maximal effort, and it assesses maximal expiratory effort as a surrogate measure for expiratory muscle strength and is useful for assessing obstructive lung disease, such as asthma. These parameters are considered to be potentially very useful in integrated measures of respiratory function in Duchenne muscular dystrophy patients.21 In addition, previous studies have shown that pulmonary function in the children with CP had characteristics of both obstructive and restrictive lung disease,2 22 23 24 25 and thus, FEV₁, FVC, and PEF were assessed as outcome measures in this study.

Shallow breathing, paradoxical breathing, and low breathing volume are commonly noted in children with CP, particularly low functioning CP, and these findings may lead to the development of widespread microatelectasis and a decrease in lung distensibility.26 27 Morbidity and mortality associated with CP is mainly related to respiratory compromise, especially in low functioning CP. Therefore, interventions for enhancing respiratory function should be included as part of the comprehensive management for children with CP.

Some previous studies, report positive effects of various exercise programs on vital capacity (VC).11 24 27 However, the effect of respiratory training in children with CP has rarely been reported. In a previous randomized controlled study by Lee, et al.,16 FRT led to significant gains in FEV₁ and FVC, but not in PEF. In that study, the FRT group consisted of only nine children, and thus, the improvement in PEF after FRT did not reach a statistically significant level. On the other hand, our randomized controlled study revealed significant improvements in FEV₁, FVC, and PEF after ISE training. FRT consists of repetitive, continuous performance of both maximal inspiration and expiration training, while ISE is designed to achieve and sustain maximal inspiration for a prolonged period using slow inspiration and deep breaths.16 28 29 Although there are some differences between FRT and ISE, both ISE and FRT are effective in enhancing pulmonary function. The ISE, which increases transpulmonary pressure, inspiratory volumes, and inspiratory muscle performance, by encouraging the patient to take long, slow, deep breaths,30 led to improvement in these parameters. The results of our study suggest that ISE is useful for enhancing both inspiratory and expiratory muscle strengthening.

According to another previous study by Kwon and Lee,9 the children at GMFCS level III had a higher gain in FVC after FRT than the children at GMFCS level I or II.31 They suggested that children at GMFCS level I or II may have already reached the upper level of their respiratory function capacity, and thus, their improvement is not significant after FRT. The normal values of FVC and FEV₁ can vary depending on various factors such as height, weight, and sex, and thus, predicted values (%) for FVC or FEV₁ are preferred to compare the results across studies. In Kwon and Lee9 and Lee, et al.'s16 previous studies, predicted values for FVC and FEV₁ were not assessed. In addition, the responses of respiratory training on pulmonary function in children with CP may differ between unilateral CP and bilateral CP. Further studies are needed to determine the best candidates for respirator training.

Respiration is an essential physiologic component for maintaining vital function and for performing physical activity in daily life.32 Respiration is also one of the key elements of physical fitness, along with muscular function and cardiovascular function.33 A recent study pointed out that respiratory muscle strength in children with CP is positively correlated with the activities of daily living, self-care, and social function.10 From this perspective, it is interesting to note whether improvement in respiratory function can lead to better exercise endurance, perception of dyspnea, and quality of life. Further studies to address this issue may be helpful for understanding the role of respiratory exercise in children with CP.

According to a previous study, MPT increases in normal children as they grew older, and MPT of normal children in the United States at the age of 8 to 15 years is between 17.1 and 20.7 sec.34 On the other hand, MPT of normal Korean children aged from 8 to15 years reportedly range from 12.6 to 15.8 sec.35 Compared to those values, the MPTs of our children are shorter. In a previous study, children with spastic CP had a shorter MPT than the normal control group.36 Also, a significant positive correlation between MPT and peak VO₂ and also between MPT and the severity of chronic heart failure (CHF) were reported in patients with CHF.37 38 On the other hand, there was no significant relationship between MPT and VC in adults with normal speech and voice.39 The proportion of VC used by individual speakers for the MPT task can vary, leading to no significant relationship between VC and MPT.40 41 42 Also, in our study, there were no significant relationships between MPT and the parameters of PFT. ISE is a breathing technique in which deep breathing exercises are performed through a device that offers visual feedback in response to inspired flow and volume. These exercises allow patients to maximally inflate their lungs and to sustain that inflation. Thus, through this exercise, improvement in breath control appears to result in the observed increase in MPT. Breathy speech, weak breath control, and short utterances are major speech and voice concerns in children with CP.43 The results of our study suggest that ISE may be helpful for enhancing breath control for speech production in children with CP. Further studies are needed to delineate the clinical relevance of the improvement in MPT in terms of speech and voice quality in children with CP.

There are some limitations of our study. Most of children of our study were at level II or III, and thus, the effects of ISE according to GMFCS level were not investigated in our study. Further studies are needed to outline optimal candidates for ISE in terms of GMFCS level. Another limitation comes from the duration of respiratory training. According to a previous report, 16 significant improvements in pulmonary function were obtained with 4 weeks of respiratory training in children with CP. Four weeks is the maximal duration of stay in our hospital in general, and thus, 4 weeks of respiratory training was selected for our study. However, the optimal duration of training in order to maximize pulmonary function needs to be clarified in children with CP through further studies.

In conclusion, this randomized controlled study demonstrated significant benefits of ISE in terms of pulmonary function and MPT in children with spastic CP. ISE is a simple and inexpensive tool for children to use, and therefore, wider use of ISE may be helpful for children at risk of pulmonary dysfunction and poor breath control in speech production.

Figures and Tables

Fig. 1

Flow chart of participant enrollment.

Fig. 2

Incentive spirometer (DHD CliniFLO®).

Table 1

Demographic and Baseline Characteristics of the Control Group and the Incentive Spirometer Treatment Group

	Control group (n=23)	ISE group (n=25)	p value^*
Age (yrs)	11.7 (2.5)	11.4 (2.3)	0.72
Gender, male (%)	11 (47.8)	15 (60.0)	0.40
Gestational age (wks)	33.3 (4.4)	32.8 (4.0)	0.60
Birth weight (kg)	2.1 (0.9)	2.0 (0.8)	0.49
Height (cm)	139.8 (16.2)	141.2 (13.4)	0.75
Weight (kg)	38.1 (12.3)	39.9 (14.9)	0.65
Body mass index (kg/m2)	19.1 (3.7)	19.4 (4.6)	0.80
GMFCS			>0.99
I	2 (8.7)	2 (8.0)
II	7 (30.4)	8 (32.0)
III	12 (52.2)	12 (48.0)
IV	2 (8.7)	3 (12.0)
Topography classification			0.78
Diplegia	17 (73.9)	20 (80.0)
Hemiplegia	3 (13.1)	1 (4.0)
Triplegia	2 (8.7)	3 (12.0)
Quadriplegia	1 (4.3)	1 (4.0)
Pulmonary function tests
FEV₁ (L)	1.4 (0.4)	1.4 (0.4)	0.62
FEV₁(% predicted)	84.4 (21.8)	81.9 (25.2)	0.72
FVC (L)	1.9 (0.7)	1.9 (0.5)	0.96
FVC (% predicted)	86.2 (21.0)	84.3 (21.0)	0.75
FEV₁/FVC (%)	71.7 (17.2)	72.8 (11.9)	0.81
Peak expiratory flow (L/min)	185.7 (60.1)	191.6 (56.2)	0.51
Maximal phonation time (sec)	9.7 (5.3)	10.2 (3.7)	0.71
GMFM-66 (%)	57.9 (24.0)	53.8 (24.9)	0.58

ISE, incentive spirometry exercise; GMFCS, Gross Motor Function Classification System; FVC, forced vital capacity; FEV₁, forced expiratory volume in 1 sec; GMFM, Gross Motor Function Measure.

Values are expressed as mean (SD) or number of participants (percentage).

^*p-values were calculated by independent t-tests or Mann-Whitney test or chi-square tests.

Table 2

Comparison of Pre- and Post-Treatment Measurements in the Control Group and the Incentive Spirometer Treatment Group

Parameters	Control group (n=23)			ISE group (n=25)			Between group p
Parameters	Baseline	Wk 4	p value	Baseline	Wk 4	p value	Between group p
FEV₁ (L)	1.35 (0.44)	1.35 (0.45)	0.848	1.40 (0.37)	1.57 (0.44)^*	0.005	0.017^†
FEV₁ (% predicted)	84.42 (21.78)	85.59 (24.15)	0.605	81.91 (25.20)	91.12 (28.24)^*	0.009	0.036^†
FVC (L)	1.94 (0.66)	1.90 (0.69)	0.511	1.95 (0.48)	2.15 (0.56)^*	0.000	0.005^†
FVC (% predicted)	86.19 (20.95)	83.31 (18.44)	0.685	84.25 (21.03)	92.18 (24.98)^*	0.001	0.031^†
FEV₁/FVC (%)	71.71 (17.23)	73.79 (15.68)	0.563	72.76 (11.91)	74.48 (13.98)	0.443	0.821
PEF (L/min)	185.65 (60.14)	194.78 (55.40)	0.473	191.60 (56.25)	217.60 (67.58)^*	0.003	0.085
MPT (sec)	9.65 (5.30)	10.06 (5.75)	0.705	10.16 (3.70)	12.13 (3.61)^*	0.001	0.008^†
GMFM-66 (%)	57.92 (23.97)	61.58 (24.24)^*	0.003	53.83 (24.93)	57.37 (23.34)^*	0.001	0.916

ISE, incentive spirometry exercise; FVC, forced vital capacity; FEV₁, forced expiratory volume in 1 sec; PEF, peak expiratory flow; MPT, maximal phonation time; GMFM, Gross Motor Function Measure.

Values are expressed as means (SD).

^*p<0.05 by paired samples t-test or Wilcoxon signed rank test, baseline versus after four weeks within each group, ^†p<0.05 by independent samples t-test or Mann-Whitney test, comparisons of pre- and post-test differences in pulmonary function between the experimental group and the control group.

Table 3

Pearson Correlation Coefficients between Gross Motor Function Measure (GMFM) and Pulmonary Function Tests

	Correlation	p value
Baseline GMFM-66 in the whole group (%)
FEV₁(L)	0.190	0.216
FVC (L)	0.214	0.164
PEF (L/min)	0.140	0.363
MPT (sec)	0.462^*	0.003
GMFM difference in the ISE group (n=25)
FEV₁ (L) difference	-0.132	0.529
FVC (L) difference	-0.094	0.655
PEF (L/min) difference	0.141	0.500
MPT (sec) difference	0.205	0.325
GMFM difference in the control group (n=23)
FEV₁ (L) difference	-0.291	0.177
FVC (L) difference	-0.253	0.245
PEF (L/min) difference	-0.123	0.577
MPT (sec) difference	0.011	0.960

ISE, incentive spirometry exercise; FVC, forced vital capacity; FEV₁, forced expiratory volume in 1 sec; PEF, peak expiratory flow; MPT, maximal phonation time.

^*Correlation is significant at the 0.05 level.

ACKNOWLEDGEMENTS

This work was supported by the Research Institute of Rehabilitation Medicine at Yonsei University College of Medicine.

Notes

The authors have no financial conflicts of interest.

References

1. Strauss D, Cable W, Shavelle R. Causes of excess mortality in cerebral palsy. Dev Med Child Neurol. 1999; 41:580–585.

2. Seddon PC, Khan Y. Respiratory problems in children with neurological impairment. Arch Dis Child. 2003; 88:75–78.

3. Ersöz M, Selçuk B, Gündüz R, Kurtaran A, Akyüz M. Decreased chest mobility in children with spastic cerebral palsy. Turk J Pediatr. 2006; 48:344–350.

4. Toder DS. Respiratory problems in the adolescent with developmental delay. Adolesc Med. 2000; 11:617–631.

5. O'Donnell DM. Pulmonary complications in neuromuscular disease. Adolesc Med. 2000; 11:633–645.

6. Sullivan PB, Lambert B, Rose M, Ford-Adams M, Johnson A, Griffiths P. Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study. Dev Med Child Neurol. 2000; 42:674–680.

7. Reyes AL, Cash AJ, Green SH, Booth IW. Gastrooesophageal reflux in children with cerebral palsy. Child Care Health Dev. 1993; 19:109–118.

8. Saito N, Ebara S, Ohotsuka K, Kumeta H, Takaoka K. Natural history of scoliosis in spastic cerebral palsy. Lancet. 1998; 351:1687–1692.

9. Kwon YH, Lee HY. Differences of respiratory function according to level of the gross motor function classification system in children with cerebral palsy. J Phys Ther Sci. 2014; 26:389–391.

10. Wang HY, Chen CC, Hsiao SF. Relationships between respiratory muscle strength and daily living function in children with cerebral palsy. Res Dev Disabil. 2012; 33:1176–1182.

11. Hutzler Y, Chacham A, Bergman U, Szeinberg A. Effects of a movement and swimming program on vital capacity and water orientation skills of children with cerebral palsy. Dev Med Child Neurol. 1998; 40:176–181.

12. So MW, Heo HM, Koo BS, Kim YG, Lee CK, Yoo B. Efficacy of incentive spirometer exercise on pulmonary functions of patients with ankylosing spondylitis stabilized by tumor necrosis factor inhibitor therapy. J Rheumatol. 2012; 39:1854–1858.

13. Scherer TA, Spengler CM, Owassapian D, Imhof E, Boutellier U. Respiratory muscle endurance training in chronic obstructive pulmonary disease: impact on exercise capacity, dyspnea, and quality of life. Am J Respir Crit Care Med. 2000; 162:1709–1714.

14. Basoglu OK, Atasever A, Bacakoglu F. The efficacy of incentive spirometry in patients with COPD. Respirology. 2005; 10:349–353.

15. Igarashi T, Konishi A, Suwa K. [The effects of incentive spirometry on pulmonary functions]. Masui. 1994; 43:770–773.

16. Lee HY, Cha YJ, Kim K. The effect of feedback respiratory training on pulmonary function of children with cerebral palsy: a randomized controlled preliminary report. Clin Rehabil. 2014; 28:965–971.

17. Speyer R. Effects of voice therapy: a systematic review. J Voice. 2008; 22:565–580.

18. Speyer R, Bogaardt HC, Passos VL, Roodenburg NP, Zumach A, Heijnen MA, et al. Maximum phonation time: variability and reliability. J Voice. 2010; 24:281–284.

19. Wang HY, Yang YH. Evaluating the responsiveness of 2 versions of the gross motor function measure for children with cerebral palsy. Arch Phys Med Rehabil. 2006; 87:51–56.

20. Yoon KA, Lim HS, Koh YY, Kim H. Normal predicted values of pulmonary function test in Korean school-aged children. J Korean Pediatr Soc. 1993; 36:25–37.

21. Mayer OH, Finkel RS, Rummey C, Benton MJ, Glanzman AM, Flickinger J, et al. Characterization of pulmonary function in Duchenne muscular dystrophy. Pediatr Pulmonol. 2015; 50:487–494.

22. Blumberg ML. Speech and respiratory impairments and related therapies in cerebral palsy. Br J Phys Med. 1955; 18:215–219.

23. Hardy JC. Lung function of athetoid and spastic qusdriplegic children. Dev Med Child Neurol. 1964; 6:378–388.

24. Bjure J, Berg K. Dynamic and static lung volumes of school children with cerebral palsy. Acta Paediatr Scand Suppl. 1970; 204:Suppl 204. 35+.

25. Kotagal S, Gibbons VP, Stith JA. Sleep abnormalities in patients with severe cerebral palsy. Dev Med Child Neurol. 1994; 36:304–311.

26. Leopando MT, Moussavi Z, Holbrow J, Chernick V, Pasterkamp H, Rempel G. Effect of a soft Boston orthosis on pulmonary mechanics in severe cerebral palsy. Pediatr Pulmonol. 1999; 28:53–58.

27. Rothman JG. Effects of respiratory exercises on the vital capacity and forced expiratory volume in children with cerebral palsy. Phys Ther. 1978; 58:421–425.

28. Bartlett D Jr. Origin and regulation of spontaneous deep breaths. Respir Physiol. 1971; 12:230–238.

29. Petz TJ. Physiologic effects of IPPB, blow bottles and incentive spirometry. Curr Rev Respir Ther. 1979; 1:107–111.

30. AARC American Association for Respiratory Care) clinical practice guideline. Incentive spirometry. Respir Care. 1991; 36:1402–1405.

31. Lee HY, Kim K. Can walking ability enhance the effectiveness of breathing exercise in children with spastic cerebral palsy? J Phys Ther Sci. 2014; 26:539–542.

32. Buchanan GF. Timing, sleep, and respiration in health and disease. Prog Mol Biol Transl Sci. 2013; 119:191–219.

33. Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ. Measurements during integrative cardiopulmonary exercise testing. In : Wasserman K, editor. Principles of exercise testing and interpretation. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins;2005. p. 76–110.

34. Finnegan DE. Maximum phonation time for children with normal voices. J Commun Disord. 1984; 17:309–317.

35. Her CM. The change of maximum phonation time, articulation diadochokinetic rate and speech rate of standardized passage: from 8 to 21 years old [Unpublished master's thesis]. Seoul: Yonsei University;2009.

36. Park ES, Rha DW, Chung HI, Park JE, Nam HS, Kim MJ. Acoustic analysis of vowel sound in children with spastic cerebral palsy. J Korean Acad Rehabil Med. 2007; 31:103–108.

37. Izawa KP, Watanabe S, Yokoyama H, Hiraki K, Morio Y, Oka K, et al. Muscle strength in relation to disease severity in patients with congestive heart failure. Am J Phys Med Rehabil. 2007; 86:893–900.

38. Izawa KP, Watanabe S, Tochimoto S, Oka K, Otobe Y, Nemoto S, et al. Maximum phonation time is related to disease severity in male chronic heart failure patients. Int J Cardiol. 2014; 174:727–728.

39. Solomon NP, Garlitz SJ, Milbrath RL. Respiratory and laryngeal contributions to maximum phonation duration. J Voice. 2000; 14:331–340.

40. Yanagihara N, Koike Y. The regulation of sustained phonation. Folia Phoniatr (Basel). 1967; 19:1–18.

41. Yanagihara N, Koike Y, Von Leden H. Phonation and respiration. Function study in normal subjects. Folia Phoniatr (Basel). 1966; 18:323–340.

42. Isshiki N, Okamura H, Morimoto M. Maximum phonation time and air flow rate during phonation: simple clinical tests for vocal function. Ann Otol Rhinol Laryngol. 1967; 76:998–1007.

43. Fox CM, Boliek CA. Intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria. J Speech Lang Hear Res. 2012; 55:930–945.

TOOLS

Similar articles